David E. I. Pyott, a director at Alnylam Pharmaceuticals ($ALNY), sold shares once on the open market in the last year, totaling $2.2 million. His most recent sale occurred on March 24, 2025. These sales rank 3,290th among nearly 12,000 individual insiders, where the average is about $8.6 million across roughly six transactions. Pyott made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | PYOTT DAVID E I | Director | A | Stock Option (right to buy) | 5893 | $0.00 | 5,893.0000 | 42,607,717 | 9999.99% | 0.01% |
| Feb. 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | PYOTT DAVID E I | Director | A | Restricted Stock Units | 3729 | $0.00 | 3,729.0000 | 42,607,717 | 9999.99% | 0.01% |
| June 5, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | PYOTT DAVID E I | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | A | Common Stock | 775 | $0.00 | 28,811.0000 | 127,651,000 | 2.76% | 0.00% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | A | Stock Option (right to buy) | 1558 | $0.00 | 1,558.0000 | 127,651,000 | 9999.99% | 0.00% |
| March 24, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Common Stock | 7440 | $88.95 | 35,476.0000 | 127,651,000 | 26.54% | 0.01% |
| March 24, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Stock Option (right to buy) | 7440 | $0.00 | 0.0000 | 127,651,000 | 100.00% | 0.01% |
| March 24, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | S | Common Stock | 7440 | $299.00 | 28,036.0000 | 127,651,000 | 20.97% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | S | Common Stock | 17560 | $220.00 | 42,926.0000 | 124,906,000 | 29.03% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | S | Common Stock | 7420 | $221.00 | 35,506.0000 | 124,906,000 | 17.29% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | S | Common Stock | 7470 | $222.00 | 28,036.0000 | 124,906,000 | 21.04% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Stock Option (right to buy) | 7420 | $0.00 | 3,830.0000 | 124,906,000 | 65.96% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Stock Option (right to buy) | 7470 | $0.00 | 3,780.0000 | 124,906,000 | 66.40% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Common Stock | 17560 | $88.95 | 45,596.0000 | 124,906,000 | 62.63% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Stock Option (right to buy) | 17560 | $0.00 | 7,440.0000 | 124,906,000 | 70.24% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Common Stock | 7420 | $70.20 | 53,016.0000 | 124,906,000 | 16.27% | 0.01% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | M | Common Stock | 7470 | $71.99 | 60,486.0000 | 124,906,000 | 14.09% | 0.01% |
| June 13, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | PYOTT DAVID E I | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| May 21, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | PYOTT DAVID E I | Director | A | Common Stock | 4720 | $0.00 | 49,750.0000 | 191,595,000 | 10.48% | 0.00% |
| May 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | PYOTT DAVID E I | Director | A | Stock Option (right to buy) | 5228 | $0.00 | 5,228.0000 | 124,906,000 | 9999.99% | 0.00% |
| May 23, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | PYOTT DAVID E I | Director | A | Common Stock | 4190 | $0.00 | 45,030.0000 | 188,963,000 | 10.26% | 0.00% |